Atlas Trials

Jasper Therapeutics, Inc.

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Jasper Therapeutics, Inc.

RecordFirmDate
A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic Asthma (NCT06592768)Jasper Therapeutics, Inc.2024-11-26
A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials (NCT06736262)Jasper Therapeutics, Inc.2024-11-26
A Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- Antihistamines (NCT06353971)Jasper Therapeutics, Inc.2024-03-18
Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU) (NCT06162728)Jasper Therapeutics, Inc.2023-11-29
JSP191 (briquilimab) in Subjects with LR-MDS (NCT05903274)Jasper Therapeutics, Inc.2023-06-19
JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation (NCT04429191)Jasper Therapeutics, Inc.2020-07-08

Track Jasper Therapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.